Rajkumar Kannan
Amministratore Delegato presso I-MAB
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Jingwu Zhang Zang | M | 68 |
I-MAB Biopharma Co., Ltd.
 I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | 8 anni |
| Roni Mamluk | M | 57 | 18 anni | |
| Richard Yeh | M | 56 |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | 2 anni |
| Pamela Klein | M | 63 | 4 anni | |
| Michael Megna | M | 53 | 6 anni | |
| Rory Nealon | M | 56 | 5 anni | |
| Joe Wiley | M | 53 | 5 anni | |
| Shuai Chen | M | 50 |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | 1 anni |
| Timothy Stonesifer | M | 56 | 2 anni | |
| Ruyi He | M | 63 | 3 anni | |
| Stephen Joyce | M | - | - | |
| Chun Kwok Au | M | 51 | 4 anni | |
| Leon Sergio Duplan Fraustro | M | 57 | 2 anni | |
| Rong Shao | M | 62 | 3 anni | |
| David Endicott | M | 58 | 2 anni | |
| Wei Fu | M | 42 | 6 anni | |
| Chia Hung Yang | M | 61 | 4 anni | |
| Richard Levy | M | 66 | 5 anni | |
| Ray Stafford | M | 77 | 8 anni | |
| Yi Fei Zhu | M | 55 | 4 anni | |
| Tracy Cunningham | M | - | 4 anni | |
| Ross Moat | M | 43 | 5 anni | |
| Helen Phillips | M | - | - | |
| Jerry Wang | M | - | - | |
| Jonathan Balch | M | - | 2 anni | |
| Min Yin | F | - |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | - |
| Julie Eastwood | F | - | 5 anni | |
| Stephen Wills | M | 67 | 5 anni | |
| Yun Han Lin | M | 46 | 7 anni | |
| John McEvoy | M | 37 | 7 anni | |
| Ian Bell | M | 54 | 2 anni | |
| George Hampton | M | 54 | 5 anni | |
| Donald Stern | M | 78 | 5 anni | |
| Royce Bedward | M | 58 | 2 anni | |
| Elizabeth Jobes | F | 57 | 4 anni | |
| Patrick Volkert Vink | M | 60 | 5 anni | |
| Alain Munoz | M | 75 | 5 anni | |
| Gary Jay Sternberg | M | - | 2 anni | |
| Andrew Zhu | M | - |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Benjamin McGraw | M | 75 | 8 anni | |
| Paul R. Fonteyne | M | 63 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 9 anni |
| Mark J. Fitzpatrick | M | 61 | 6 anni | |
| J. Carroll | M | 74 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 9 anni |
| Casey C. Kopczynski | M | 62 | 17 anni | |
| Marla Persky | F | 68 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 8 anni |
| Rainer Lichtenberger | M | 65 | 14 anni | |
| Xiu Xuan Zhu | M | 64 | 3 anni | |
| David Stack | M | 72 | 7 anni | |
| Richard Croarkin | M | 69 | 7 anni | |
| Michael du Toit | M | 71 | 7 anni | |
| John W. LaRocca | M | 59 | 4 anni | |
| Peter John McDonnell | M | 66 | 2 anni | |
| Dawn Schottlandt | F | - | 1 anni | |
| Veit Ulshöfer | M | 61 | 23 anni | |
| Julie McHugh | F | 59 | 7 anni | |
| Matthew Emmens | M | 72 | 4 anni | |
| Wolfram Carius | M | 63 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | - |
| Desiree Ralls-Morrison | F | 57 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 4 anni |
| Drew Enamait | M | 50 | 6 anni | |
| Thomas A. Mitro | M | 66 | 9 anni | |
| Ursula B. Bartels | F | 66 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 5 anni |
| Brendan Classon | M | - | - | |
| Scott Minick | M | 72 | 14 anni | |
| John Doyle | M | 46 | - | |
| John Scarlett | M | 73 | 6 anni | |
| Rick Ryan | M | - | 11 anni | |
| Gerald D. Cagle | M | 79 | 9 anni | |
| David Gryska | M | 68 | 4 anni | |
| lee Giguere | M | 43 | 2 anni | |
| Michael McCleerey | M | - | 8 anni | |
| John Thero | M | 63 | 6 anni | |
| Anand Varadan | M | 57 | 1 anni | |
| Christophe Couturier | M | 58 | 12 anni | |
| Joseph Lyons | M | - | 1 anni | |
| Giuseppe Ciaramella | M | 55 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 1 anni |
| Malte Peters | M | 61 | 1 anni | |
| Lynne Sullivan | F | 58 | 8 anni | |
| Jennifer Laux | F | - |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 1 anni |
| Crocifissa Attardo | F | 62 | 23 anni | |
| Nigel Williams | M | - | 11 anni | |
| Olaf Klinger | M | 59 | 4 anni | |
| David Smoller | M | 60 | 2 anni | |
| Irwin Scher | M | 84 | 3 anni | |
| David S. McCullough | M | 59 | 5 anni | |
| Lothar H. Finke | M | - | 9 anni | |
| Hans-Joachim Lohrisch | M | 75 | 21 anni | |
| Hans-Joachim Langmann | M | - | 39 anni | |
| Achim Schäffler | M | - | 13 anni | |
| Dorothea Wenzel | M | 55 | 17 anni | |
| Kenneth B. Newman | M | 66 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 3 anni |
| Vincent R. Anicetti | M | 69 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 1 anni |
| Bernhard R. M. Ehmer | M | 69 | 8 anni | |
| Michael Becker | M | 76 | 13 anni | |
| Thomas Lander | M | 71 | - | |
| Thomas Kuhn | M | 50 | - | |
| Daniel Cravo | M | - | - | |
| Uta Kemmerich-Keil | F | 58 | 19 anni | |
| Peter F. Lang | M | 52 | - |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 58 | 59.18% |
| Germania | 24 | 24.49% |
| Regno Unito | 15 | 15.31% |
| Cina | 5 | 5.10% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Rajkumar Kannan
- Contatti personali
